Attendee search 

Dr. Fiebig is an entrepreneur and biopharma executive with over 14 years of management experience in academia, industry and not-for-profit (government) organizations.  He is the Senior Director, Strategic Programs at the Ontario Bioscience Innovation Organization (OBIO) and leads OBIO’s Capital Access Advisory Program which has received significant support from FedDev Ontario to strengthen Ontario’s cadre of investable human health technology companies, increasing high value deal flow.  Prior to his role at OBIO, Dr. Fiebig was CSO and VP of Research Programs at Ontario Genomics, a government funding organization, where he oversaw an $800M research program portfolio.  During this time he was responsible for more than 10 funding competitions, a team of research program managers, and Ontario Genomics’ strategic approach to identifying, cultivating, and raising funds for genomics and proteomics projects and platforms in Ontario.  As Senior Director, Structural Biology and Computational Chemistry at Affinium Pharmaceuticals in Toronto he led the structural biology and computational chemistry teams and a 20 FTE strategic alliance with Pfizer on structure-based drug discovery focused on infectious disease.  Prior, Dr. Fiebig founded and managed MRPharm GmbH, a fee-for-service and drug discovery biotech start-up in Frankfurt, Germany and was a lead scientist with Xencor in Los Angeles responsible for improving their automatic computational protein design platform.  Dr. Fiebig has a broad scientific background in the physical and biomedical fields. He trained at Yale University (Post Doctorate), Oxford University (Post Doctorate), University of California at San Francisco (PhD), and the Technical University Munich (undergraduate). He co-authored numerous scientific publications and holds several patents.